CLINICAL TRIALS PROFILE FOR FEMHRT

All Clinical Trials for FEMHRT

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00600106 ↗	Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study	Completed	Allegheny University	N/A	1999-12-01	The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinating center, the investigators will be performing P31 MRS core lab analyses; hormone core lab analyses; lipid core lab analyses; glucose, insulin and HOMA core lab analyses; exercise stress test/Holter monitor core lab analyses; brachial artery reactivity test core lab analyses; full study data analyses for manuscript preparation and the writing and submission and publication of manuscript. The main trial duration: December 1999 - May 2003. The ancillary data analysis project duration: April 2006 - March 2010.
NCT00600106 ↗	Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study	Completed	Johns Hopkins University	N/A	1999-12-01	The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinating center, the investigators will be performing P31 MRS core lab analyses; hormone core lab analyses; lipid core lab analyses; glucose, insulin and HOMA core lab analyses; exercise stress test/Holter monitor core lab analyses; brachial artery reactivity test core lab analyses; full study data analyses for manuscript preparation and the writing and submission and publication of manuscript. The main trial duration: December 1999 - May 2003. The ancillary data analysis project duration: April 2006 - March 2010.
NCT00600106 ↗	Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study	Completed	Parke-Davis	N/A	1999-12-01	The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinating center, the investigators will be performing P31 MRS core lab analyses; hormone core lab analyses; lipid core lab analyses; glucose, insulin and HOMA core lab analyses; exercise stress test/Holter monitor core lab analyses; brachial artery reactivity test core lab analyses; full study data analyses for manuscript preparation and the writing and submission and publication of manuscript. The main trial duration: December 1999 - May 2003. The ancillary data analysis project duration: April 2006 - March 2010.
NCT00600106 ↗	Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study	Completed	University of Alabama at Birmingham	N/A	1999-12-01	The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinating center, the investigators will be performing P31 MRS core lab analyses; hormone core lab analyses; lipid core lab analyses; glucose, insulin and HOMA core lab analyses; exercise stress test/Holter monitor core lab analyses; brachial artery reactivity test core lab analyses; full study data analyses for manuscript preparation and the writing and submission and publication of manuscript. The main trial duration: December 1999 - May 2003. The ancillary data analysis project duration: April 2006 - March 2010.
NCT00600106 ↗	Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study	Completed	University of Florida	N/A	1999-12-01	The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinating center, the investigators will be performing P31 MRS core lab analyses; hormone core lab analyses; lipid core lab analyses; glucose, insulin and HOMA core lab analyses; exercise stress test/Holter monitor core lab analyses; brachial artery reactivity test core lab analyses; full study data analyses for manuscript preparation and the writing and submission and publication of manuscript. The main trial duration: December 1999 - May 2003. The ancillary data analysis project duration: April 2006 - March 2010.

Clinical Trial Conditions for FEMHRT

Condition Name

Condition Name for FEMHRT
Intervention	Trials
Myocardial Ischemia	1

Condition MeSH

Condition MeSH for FEMHRT
Intervention	Trials
Myocardial Ischemia	1
Ischemia	1
Coronary Artery Disease	1

Clinical Trial Locations for FEMHRT

Trials by Country

Trials by Country for FEMHRT
Location	Trials
United States	1

Trials by US State

Trials by US State for FEMHRT
Location	Trials
California	1

Clinical Trial Progress for FEMHRT

Clinical Trial Phase

Clinical Trial Phase for FEMHRT
Clinical Trial Phase	Trials
N/A	1

Clinical Trial Status

Clinical Trial Status for FEMHRT
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for FEMHRT

Sponsor Name

Sponsor Name for FEMHRT
Sponsor	Trials
University of Alabama at Birmingham	1
University of Florida	1
University of Pittsburgh	1

Sponsor Type

Sponsor Type for FEMHRT
Sponsor	Trials
Other	6
Industry	1